Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  COMPANY NEWS
Company News      
Divi's Laboratories Ltd.
Change Company   
BSE Code 532488
ISIN Demat INE361B01024
Book Value 582.07
NSE Code DIVISLAB
Dividend Yield % 0.46
Market Cap 1748853.91
P/E 74.87
EPS 88.00
Face Value 2  
12-Aug-2025 Divi's Laboratories informs about transcript of e...
07-Aug-2025 Divi’s Laboratories reports 27% rise in Q1 consol...
07-Aug-2025 Divis Laboratories informs about press release
26-Jul-2025 Divis Laboratories informs about board meeting
15-Jul-2025 Divi’s Laboratories informs about certificate
30-Jun-2025 Divi’s Laboratories informs about closure of tra...
26-May-2025 Divi's Laboratories inks pact with global pharma ...
26-May-2025 Divi's Laboratories zooms on inking pact with glo...
24-May-2025 Divi's Laboratories informs about updates
17-May-2025 Divis Laboratories board approves dividend
16-May-2025 Divis Laboratories informs about annual secretari...
30-Apr-2025 Divi's Laboratories informs about cessation of SMP
21-Apr-2025 Divi's Laboratories inks supply agreement with gl...
21-Apr-2025 Divi's Laboratories surges on inking supply agree...
31-Mar-2025 Divis Laboratories informs about trading window c...
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.